CYCLERION THERAPEUTICS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
CYCLERION THERAPEUTICS, INC. (CYCN) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $11.61 million as of 2021-03-31, per its 10-Q filed 2021-04-30.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2021-04-30
- 2021-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $11.61M.
- 2020-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $12.24M.
- 2020-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $12.89M.
- 2020-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $25.44M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2021-03-31 | $11.61M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $12.24M 10-K · filed 2021-02-25 |
| 2020-09-30 | $12.89M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $25.44M 10-Q · filed 2020-08-03 |
| 2020-03-31 | $26.62M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $46.77M 10-K · filed 2020-03-12 |
| 2019-09-30 | $48.77M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $50.77M 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |